Release

Today’s Research Reports on Trending Tickers: Tandem Diabetes Care and DaVita

Wall Street retreated from records on Thursday, on news that U.S. President Donald Trump wants to move ahead with his plan to slap tariffs on $200 billion worth additional Chinese imports. Investors will appear to fret if current administration remains aggressive towards its trade policies. The Dow Jones Industrial Average closed 0.53 percent lower to settle at 25,986.92, while the S&P 500 Index dropped 0.44 percent to close at 2,901.13. The Nasdaq Composite Index edged declined 0.26 percent to close at 8,088.36.

RDI Initiates Coverage on:

Tandem Diabetes Care, Inc.
https://rdinvesting.com/news/?ticker=TNDM

DaVita Inc.
https://rdinvesting.com/news/?ticker=DVA

Tandem Diabetes Care’s stock jumped 7.62% Thursday, to close the day at $44.05. The stock recorded a trading volume of 3,050,250 shares, which was above its three months average volume of 2,933,209 shares. In the last year, Tandem Diabetes Care’s shares have traded in a range of 2.14 – 44.57. The share price has gained 1958.41% from its 52 week low. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $31.13 is above its 200-day moving average of $15.54. Shares of Tandem Diabetes Care have gained roughly 77.33 percent in the past month and are up 1766.53 percent year-to-date.

Access RDI’s Tandem Diabetes Care, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=TNDM

On Thursday, shares of DaVita recorded a trading volume of 5,077,659 shares, which was above the three months average volume of 1,277,150 shares. The stock ended the day 8.95% lower at $66.51. The share price has fallen 17.59% from its 52 week high with a 52 week trading range of 52.51 – 80.71. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $71.69 is above its 200-day moving average of $69.10. Shares of the company are trading at a Price to Earnings ratio of 22.69. Shares of DaVita have fallen roughly 4.73 percent in the past month and are down 7.94 percent year-to-date.

Access RDI’s DaVita Inc. Research Report at:
https://rdinvesting.com/news/?ticker=DVA

Our Actionable Research on Tandem Diabetes Care, Inc. (NASDAQ:TNDM) and DaVita Inc. (NYSE:DVA) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

[email protected]

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.